The data on Pfizer's GLP-1 offer early evidence that the injection can be administered less frequently than existing drugs ...

Eli Lilly and Novo Nordisk may want to enjoy their duopoly while they can.

Eli Lilly’s Zepbound is still viewed as the leading weight-loss shot, according to a ...

Add Yahoo as a preferred source to see more of our stories on Google. The recommendation, made by the CDC's Advisory Committee on Immunization Practices, acknowledges the increased risk of severe ...

Pfizer (NYSE:PFE) shares fell on Wednesday after The Wall Street Journal reported that U.S. officials have started an investigation into whether the New York-based pharma giant deliberately delayed ...